Neurochem’s Supplement Launch In U.S. On Hold Due To DSHEA Question
This article was originally published in The Tan Sheet
Executive Summary
Neurochem plans to launch a failed Alzheimer's drug candidate as a dietary supplement in Canada this year and in Europe and Japan in 2009, but has not determined whether it will make the product available in theU.S., company executives said Feb. 21